Aeolus Pharmaceuticals, Inc.
Financials data is not available for this stockFinancials details for this stock are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.Aeolus Pharmaceuticals, Inc. (AOLS) Cash Flow Analysis
Listed in the Healthcare sector and focused on the Drug Manufacturers - Specialty & Generic space, Aeolus Pharmaceuticals, Inc. trades at $0.00, with a market valuation of N/A.
Cash Flow Overview
A thorough cash flow breakdown of Aeolus Pharmaceuticals, Inc. reveals how funds are generated and allocated. It highlights three essential categories: operational inflows and outflows, investment-related expenditures, and cash changes tied to financing strategies.
Key Cash Flow Metrics
Financial Position Indicators
Stock Performance Summary
Aeolus Pharmaceuticals, Inc. has shown the following performance over different time periods:
Company Information
Investment Metrics
Understanding Cash Flow Statements
Unlike income reports that may reflect accruals, cash flow statements document only real-time cash activity, capturing how funds enter and exit a company, which makes them a key tool in assessing financial liquidity.
Three Components of Cash Flow:
Operating Activities
Operating activities generate company's cash flow
Investing Activities
Cash used for investments in assets, acquisitions, or securities
Financing Activities
Cash from debt, equity financing, and dividend payments
Data Update: Financial data is updated regularly based on company filings. Last earnings announcement: December 23, 2024.All financial metrics are trailing twelve months (TTM) unless otherwise specified. Currency: USD. Exchange: PNK.
Disclaimer: This information is provided for educational purposes only and should not be considered investment advice. Please conduct your own research and consult with financial advisors before making investment decisions.
Aeolus Pharmaceuticals, Inc. (AOLS) Cash Flow Analysis
The cash flow statement reveals the Aeolus Pharmaceuticals, Inc. (AOLS) liquidity trends, with operating cash flow per share at $0.00, reflecting core business performance. Investing activity changes were N/A, indicating capital expenditures or asset sales, while financing activity shifted by N/A, showing debt or equity movements. Free cash flow per share was $0.00, highlighting funds available for growth or shareholder returns. Year-over-year change in operating cash flow is N/A, demonstrating financial health shifts. For deeper insights, compare these figures with income statements and balance sheets to assess sustainability and strategic priorities.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan